Skip to main content

Hit enter to search or ESC to close

Solutions
- - Solutions
    
    Transform your drug development journey with Certara’s comprehensive solutions. From molecule to market, we seamlessly integrate science, technology, strategic and regulatory expertise to solve your unique challenges.
    Discover more
- - Strategic Leadership
    
    Unify insights to accelerate drug development and achieve development milestones. Partner with Certara to unlock your pipeline’s potential.
    Learn more
Software
- - Our software
    
    Certara’s software solutions offer transformative approaches across all drug development phases, aligning with recognized industry standards. By integrating advanced modeling, analytics, and automation, they break down silos, streamline workflows, and drive regulatory success.
    View all
- - Software by solution
    Regulatory Discovery Preclinical Early Clinical Late Clinical Market Access & Commercial View software
Services
- - Our services
    
    Transform drug development with our tailored services. From predictive modeling to market access strategies, Certara’s integrated services enhance decision-making, streamline processes, and make your drug a safer bet.
    View all
- - Services by solution
    Regulatory Discovery Preclinical Early Clinical Late Clinical Market Access & Commercial View services
Customers
- - Customers
    
    Certara tailors solutions for biotech, pharma, and CROs, addressing unique challenges to drive success.
    Learn who we work with
- - Biotech
    
    Fuel your breakthrough pipeline. With tailored guidance and integrated services, Certara helps biotech companies transform one success into sustainable growth and attract critical investment.
  - Large Pharma
    
    Open up silos, prioritize effectively. Certara empowers large pharma to optimize decision-making, align priorities, and achieve delivery across global teams and complex pipelines.
- - CRO
    
    Maximize efficiency, align seamlessly. Certara’s cutting-edge solutions ensure CROs stay ahead, improve client alignment, and deliver results with unmatched speed and precision.
- - Transforming Partnerships
    
    Certara collaborates with leading biotech, pharma, and CRO partners to tackle complex challenges, deliver innovation, and shape the future of healthcare.
    Learn more
Resources
- - Resources
    
    With over 1,000 articles spanning categories and solutions, Certara’s resources is a geek haven. It’s all here—built for scientists who dare to think different.
    View all
- - Resources by solution
    Regulatory Discovery Preclinical Early Clinical Late Clinical Market Access & Commercial View all resources
Company
- - Explore Certara
    
    With over 1,550+ employees in more than 30 countries, over 28% of which have PhDs, our vision is to transform drug development for good.
    Learn more about us
- - Careers at Certara
    
    Join a global leader transforming the future of drug development. Explore opportunities to innovate, grow, and make a difference in transforming lives.
    Visit careers site
Contact Us
Login

search

Solutions
Software
Services
Resources
Company
Contact
Login

search

Solutions
Software
Services
Resources
Company
Contact
Login

Home / Legal Notice / Projet COVID-19 – Note d’information collective

Projet COVID-19 – Note d’information collective

View Fullscreen

Newsletter sign up

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.

Quick links

Our Story
Investors
Careers
Locations
News
Services
Software
Resources

Solutions

Regulatory
Discovery
Preclinical
Early clinical
Late clinical
Market access and commercial
Strategic Leadership

Contact

Sales inquiry
Technical support hub

© 2025 Certara. All Rights Reserved. | Privacy policy

x-twitter
facebook
linkedin
youtube